Journal article

The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm.

Viswanathan Mohan, Mark E Cooper, David R Matthews, Kamlesh Khunti

Diabetes Therapy | Published : 2019


There is currently a worldwide epidemic of type 2 diabetes (T2D) that is predicted to increase substantially in the next few years. With 80% of the global T2D population living in low to middle-income countries, there are issues with cost and of access to appropriate medicines. The objective of this symposium was to provide an overview of the efficacy and safety of glucose-lowering drugs, focussing in particular on sulfonylureas (SUs) in patients with T2D using data taken from both randomised controlled trials (RCTs) and real-world studies, the application of strategies to ensure optimal patient adherence and clinical outcomes, and the optimal use of SUs in terms of dose adjustment and agent..

View full abstract

University of Melbourne Researchers